AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years
AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years ©89Stocker, towfiqu barbhuiya via Canva Key Takeaways AbbVie lowered its 2026 adjusted EPS guidance to $13.76 to $13.96 on Oct. 5, reflecting $1.25 billion of acquired IPR&D and milestone expense. Altria yields 6.2% against AbbVie’s 2.6%, while AbbVie raised its dividend
AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years Read More »








